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ABSTRACT 
Tissue engineering is an important branch of regenerative medicine that uses cells, materials 
(scaffolds), and suitable biochemical and physicochemical factors to improve or replace specific 
biological functions. In particular, the control of cell behavior (namely, of cell adhesion,        
proliferation and differentiation) is a key aspect for the design of successful therapeutical       
approaches. In this study, poly(lactic-co-glycolic acid) (PLGA)  fiber mats were prepared using 
the electrospinning technology (the fiber diameters were in the micrometer range). Furthermore, 
the electrospun fiber mats thus formed were functionalized using the layer-by- layer (LbL)   
technique with chitosan and alginate (natural and biodegradable polyelectrolytes having opposite 
charges) as a mean for the immobilization of pDNA/dendrimer complexes. The polyelectrolyte 
multilayer deposition was confirmed by fluorescence spectroscopy using fluorescent-labeled 
polyelectrolytes. The electrospun fiber mats coated with chitosan and alginate were successfully 
loaded with complexes of pDNA and poly(amidoamine) (PAMAM) dendrimers (generation 5) 
and were able of releasing them in a controlled manner along time. In addition, these mats     
supported the adhesion and proliferation of NIH 3T3 cells and of human mesenchymal stem cells 
(hMSCs) in their surface. Transfection experiments using a pDNA encoding for luciferase 
showed the ability of the electrospun fiber mats to efficiently serve as gene delivery systems. 
When a pDNA encoding for bone morphogenetic protein-2 (BMP-2) was used, the osteoblastic 
differentiation of hMSCs cultured on the surface of the mats was promoted. Taken together, the 
results revealed that merging the electrospinning technique with the LbL technique, can be a 
suitable methodology for the creation of biological active matrices for bone tissue engineering. 
 
 
 
 
 
KEYWORDS: Electrospinning; layer-by-layer; gene delivery; human mesenchymal stem cells; 
osteoblastic differentiation 
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RESUMO  
 
A engenharia de tecidos constitui um ramo importante da medicina regenerativa que usa células, 
materiais (matrizes) e fatores bioquímicos e físico-químicos adequados para melhorar ou 
substituir funções biológicas. Em particular, o controlo do comportamento celular 
(nomeadamente da adesão, proliferação e diferenciação celulares) é um aspeto muito importante 
a considerar no design de abordagens terapêuticas. Neste estudo, foram preparadas matrizes de 
poli(D,L-ácido láctico-co-glicólico) (do in l s, “PLGA”) usando a técnica de electrofiação (os 
diâmetros das fibras situaram-se na escala micro). Adicionalmente, as matrizes foram 
funcionalizadas usando a técnica de camada-sob-camada  em in l s, “layer-by-layer”, L L  
usando quitosano e alginato (polielectrólitos naturais e biodegradáveis com cargas opostas) como 
uma forma de imobilizar complexos de DNA plasmídico (pDNA)  e dendrímeros. A deposição 
das multicamadas de polielectrólitos foi confirmada por espectroscopia de fluorescência usando 
polielectrólitos marcados com sondas fluorescentes. As matrizes revestidas com quitosano e 
alginato conseguiram ser carregadas com complexos de pDNA  e dendrímeros  de 
poli(amidoamina) (PAMAM) (geração 5) e de os libertar de forma controlada ao longo do tempo. 
Adicionalmente, estas matrizes mostraram ser capazes de suportar a adesão e proliferação de 
células NIH 3T3 e de células humanas estaminais mesenquimatosas à sua superfície. As 
experiências de transfecção com pDNA que codificava a enzima luciferase mostraram a 
capacidade das matrizes para funcionar como sistemas de entrega de genes. Quando foi usado 
um pDNA que codificava a proteína morfogenética do osso-2  do in l s, “BMP-2” , a 
diferenciação osteoblástica das células estaminais mesenquimatosas foi promovida. No seu 
conjunto, os resultados revelaram que a técnica de electrofiação, juntamente com a de LbL, 
constituem metodologias adequadas para a criação de matrizes biologicamente ativas para a 
engenharia de tecido ósseo. 
 
 
KEYWORDS: Electrofiação; camada sob camada; entrega de genes; células estaminais 
mesenquimais humanas; diferenciação osteoblástica   
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CHAPTER 1 
INTRODUCTION  
1.1. The electrospinning technique 
Tissue engineering, one of the key branches of regenerative medicine, is an interdisciplinary 
field that joins the area of materials engineering with that of life sciences towards the             
development of functional substitutes for injured or damaged tissues (Figure 1).
1
 In its classic 
approach, tissue engineering combines cells, materials (scaffolds), and suitable biochemical and 
physico-chemical factors to obtain a biological tissue made in vitro that can be later implanted in 
the human body.
2
 Among these, the scaffolds, where cells attach to generate the new tissue, play 
an important role. Scaffolds consisting of 2D or 3D networks can be prepared. Scaffolds are not 
only responsible for the structural support of the tissue under construction, but can also be used 
to provide biochemical and physico-chemical signals that are perceived by cells, and thus       
influence their proliferation and differentiation.
1-3
 Scaffolds having a high surface area to volume 
ratio are usually good candidates for tissue engineering as they present a large area for tissue 
growth. Scaffolds should thus present adequate mechanical properties, and also the right        
porosity, pore size and pore interconnectivity to be used as a functional biomaterials in tissue 
engineering.
4
   
2 
 
 
Figure1. Schematic representation of applications of tissue engineering.
5
 
 
Recently, nano/micro fibrous scaffolds have drawn much attention due to their excellent 
physical and chemical properties, such as high aspect ratio, large specific surface area and high 
porosity.
6,7
 These scaffolds may be used to mimic the extracellular matrix microenvironment and 
be useful in tissue engineering/regeneration applications.
8
 In order to produce nano/micro fibrous 
mats/scaffolds, various procedures have been assayed, like mechanical drawing, template-based 
synthesis, phase separation, self-assembly and electrospinning.
9
 Among these methods,          
electrospinning has been widely investigated by researchers as a cost-effective technology that 
can produce continuous non-woven fibrous mats with fiber diameters in the nano or microscale, 
a feature that distinguishes it from the classical non-woven fiber fabrication techniques.
10
      
Electrospun fibrous scaffolds possessing excellent properties (high surface-to-volume ratio,    
tunable porosity), provides the possibility to be prepared in different sizes and shapes.
11,12
 In   
addition, the fibrous scaffolds can be made of different polymers/materials and its composition 
can be controlled to achieve the desired properties.  
3 
 
Electrospinning was first proposed by Anton Formhals in 1934.
13
 However, only in the 
90’s it started to have the deserved attention.14 The basic electrospinning system consists of four 
parts, namely the syringe pump, a source of high voltage, a spinneret, and a grounded collector.
15
 
Figure 2 shows a schematic representation of an electrospinning machine.  The syringe pump is 
used to pressurize the polymer solution in the syringe. Throughout the process of fiber formation, 
a high voltage (tens of kV) is applied to the end of the capillary containing the liquid solution 
(usually a polymer solution). Once the electric field intensity increases, the hemispherical surface 
of the liquid at the end of the capillary extends, presenting a conical shape known as the “Taylor 
cone”.16 By increasing the electric field further, the critical value at which the repulsive         
electrostatic force overcomes the surface tension is reached, and a jet of liquid is ejected from the 
tip of the Taylor cone. Then, the strand of polymer solution goes through a process of instability 
and lengthening, during which solvent evaporates.
17
 The fibers are then deposited on the        
collector, resulting in a non-woven fibrous layer.
18
 Fibers can be deposited onto the collector in a 
random or in a ordered manner according to the desired applications.
19
  
Electrospinning is, thus, a relatively simple method of producing nano/micro fiber mats 
where several parameters can be adjusted to tune the properties of the electrospun fibers. These 
parameters are generally divided into three groups.
20
 First, one should consider the parameters 
related with the solution. Solution variables include the viscosity, the concentration, the         
molecular weight of the polymer, the surface tension, the dipole moment, the dielectric constant, 
and the conductivity (some of these properties are interdependent). Second, there are variables 
associated with the electrospinning process itself. These factors include the applied voltage, the 
distance of the electrode from the collector, the flow rate, the collector composition and         
4 
 
geometry, and the design of the needle tip. Finally, environmental variables should be considered, 
like the temperature, and the relative humidity. 
 
Figure 2. Schematic representation of electrospinning.
21
  
 
Through electrospinning, various organic and inorganic/polymer hybrid composite 
nano/micro fibers have been produced for biological applications.
22,23
 An important advantage of 
the electrospinning technique is that it can be used to prepare bioactive scaffolds for tissue            
engineering applications through the immobilization of growth factors and/or differentiation  
factors (or the genes that codify them) in the fibers by chemical or physical methods.
24
 In this 
process, the bioactive molecules (proteins or genes) can be complexed (or chemically linked) to 
nanocarriers (non-viral vectors) to facilitate their uptake by cells.
25
 For example, PEI/pDNA  
polyplexes (plasmids encoding VEGF and bFGF were used together with PEI as non-viral     
vector) emulsified in a mixture of PELA (obtained by bulk ring opening polymerization of    
lactide/PEG) and PEG (polyethylene glycol) solutions were electrospun to produce pDNA     
5 
 
containing nanofibers. The nanofibrous scaffolds thus prepared were able to promote cell       
attachment and viability, cell transfection and protein expression (extracellular secretion of    
collagen type IV and laminin). In vivo studies showed that, in comparison with pDNA polyplex 
infiltrated fibrous mats, these bioactive nanofibers diminished the inflammation reaction and 
enhanced the generation of microvessels and formation of mature vessels.
26
 In another study, the 
bone morphogenetic protein-2 (BMP-2) plasmid was immobilized in fiber scaffolds in three  
different ways: after fiber preparation, by dripping with naked pDNA (A) or pDNA/chitosan 
polyplexes (B); by mixing the pDNA/chitosan complexes with the solution containing the fiber 
components before electrospinning (C). After, they analyzed each situation in terms of potential 
for bone regeneration in vivo (in nude mice). The experiments revealed that, after 4 weeks of 
treatment, the scaffolds of the group A had a better performance than the scaffolds of the group 
B. The scaffolds of group C released the pDNA more slower than the rate of bone healing and, 
so, it was not possible to take conclusions from those experiments. Overall, the results showed 
the potential of the electrospun nanofibers to deliver bioactive compounds. 
27 
 
 
  
Indeed, the scaffolds that can release signaling molecules continuously after implantation in 
the body are expected to enhance tissue regeneration in the defect area and conduct to a more                       
efficient therapy.  
 
1.2. The layer-by-layer self-assembly technique (LbL) 
The layer-by-layer (LbL) self-assembly technique is a simple, powerful and highly versatile 
technique that has a huge scientific and technologic interest since it can be used for the          
6 
 
preparation of functional materials with tailored properties. The LbL self-assembly technique 
was first introduced in the year 1992 by the scientist Gero Decher.
28
 In a typical LbL assembly 
process, polyelectrolytes (polyanions and polycations) with opposite charges are alternately   
deposited over a surface based on their electrostatic interaction. The process leads to the        
formation of multilayered composite films with desired thickness. Figure 3 illustrates the LbL 
assembly process on fibrous scaffolds.   
The major advantage of the LbL technique is that the thickness, morphology, and      
composition of the resultant films can be controlled by varying the number of polymer           
adsorption cycles and by changing the composition of the layer components.
29
 By using the LbL 
assembly approach, a broad range of materials including polymers, nanoparticles, and             
biomolecules are able to be assembled onto substrates of varying geometry (e.g., planar surfaces, 
colloids, and fibers, etc.) to form functional nanostructured materials.
30
 In particular, the       
combination of the LbL assembly technique with electrospun fibers has drawn much attention 
for producing multifunctional biomaterials to be used in tissue engineering. For example,       
Luo et al. fabricated novel carbon nanotube-containing nanofibrous polysaccharide scaffolding 
materials via the combination of electrospinning and LbL self-assembly techniques for tissue 
engineering applications.
31
 In that study, electrospun cellulose acetate nanofibers were           
alternatively assembled with positively charged chitosan and negatively charged multiwalled 
carbon nanotubes or sodium alginate via the LbL technique. It showed that the incorporation of         
multiwalled carbon nanotubes in the multilayered cellulose acetate fibrous scaffolds tended to 
endow the fibers with improved mechanical properties and promote fibroblast attachment, 
spreading, and proliferation when compared with the native fibrous mats. The LbL technique is, 
indeed, suitable for biomedical applications since all the process is conducted in water and     
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because of the possibility to use it for the immobilization of bioactive molecules (growth and 
differentiation factors or the genes that codify them).
32,33
 The technique may even allow the     
controlled delivery of bioactive molecules along the time. 
 
 
 
Figure 3. Illustration of the LbL technique applied to fiber mats. Adapted from ref.
34
  
 
1.2.1. Polyelectrolytes used in the LbL technique 
A polymer is the chemical association of small structural units called monomers. Hence, it is 
considered to be a large molecule. Polymers can be naturally derived (e.g. collagen, chitosan, 
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cellulose, etc.), as well as synthetically produced (e.g. polystyrene, polyethyleneglycol,           
polyacrylate, etc.).
35
 Polyelectrolytes are polymers made of monomers that contain groups that 
can be ionized when the polymer is dispersed in an aqueous solution. These polymers can be 
further sub-divided into those where the charge density depends on pH (weak polyelectrolytes) 
and those where the charge density is independent of pH (strong polyelectrolytes).  
In the present study, the polycation chitosan and the polyanion sodium alginate were used 
as polyelectrolytes for the LbL technique. This pair of polyelectrolytes is extensively used in 
biomedical applications.
36-38
   
Alginate 
Alginate (or alginic acid) is a naturally available anionic polysaccharide polymer which was first 
discovered by Stanford in 1881. Usually, for commercial purposes, alginate is obtained from 
brown seaweed.
39
 Alginate has a linear structure and is composed of two types of uronic acids, 
namely guluronic (G) and mannuronic (M) acids (Figure 4). Indeed, it is a linear polymer made 
of 1,4-linked β-D-mannuronic acid and α-L-guluronic acid, being a block copolymer of the two 
monomers.
40 The number ratio between M and G strongly determines the properties of alginate 
such as its swelling behavior, gel strength, etc..
41
 The alginic acid as such is insoluble in water, 
so it is treated with salts, like sodium, potassium or ammonium, to become soluble in water.  
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Figure 4. Chemical structure of alginic acid.  
 
Due to its easy ionization in water, biocompatibility and biodegradability, alginate has 
found wide applications in the biomedical field, food and beverage industry, cosmetics, animal 
food, textile industry, etc..
42
  
 
Chitosan 
Chitosan is a well known cationic polysaccharide polymer that is produced by deacetylation of 
chitin which was discovered in 1811 by Henri Braconnot who worked on mushrooms. Chitin is 
naturally available from the exoskeleton of marine organisms such as crab, shrimps, etc.. It is 
also available from insects and plants.
43
 Chitosan is a linear polymer composed of β-(1-4)-linked 
D-glucosamine and N-acetyl-D-glucosamine (Figure 5). The degree of deacetylation of chitosan 
is significant for its properties.
44,45
 Chitosan has a high density of amino groups  that confer it a 
positive charge at neutral pH.
46
 Its biodegradability makes it widely used in the biomedical field, 
like in drug delivery, gene delivery, tissue engineering, etc..
47,48
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    Figure 5. Chemical structure of chitosan. 
1.3. Poly (lactic-co-glycolic acid) (PLGA) 
Poly(lactic-co-glycolic acid) (PLGA) is a polymer largely applied in the biomedical field due to 
its biodegradability properties, that is, the  ester linkages established between monomers can be 
easily hydrolyzed in the aqueous physiological environment (Figure 6).
49
 The PLGA monomer 
molar ratio is an important parameter that is responsible for the polymer mechanical strength, 
degree of crystallinity, swelling behavior and capacity to be hydrolyzed.
50
 Importantly, for the 
monomer molar ratio 50:50 (moles of lactic acid:moles of glycolic acid),  the PLGA is reported 
to be hydrolyzed faster than for other monomer molar ratios.
51
 It is reported that PLGA can    
undergo complete biodegradation in aqueous media.
52
  
Nowadays, PLGA fibers are produced using the electrospinning technique to form tissue 
scaffolds.
53-55
 However, the properties of the scaffolds are also strongly dependent on their   
preparation conditions. For instance, the mechanical strength of a scaffold and its porosity     
features are key factors in tissue engineering. If the mechanical properties/porosity features of a 
scaffold are not good enough, then the scaffold will not successfully meet its purposes.
56
 The 
PLGA polymer is reported as being biocompatible, biodegradable and as adequate to form     
11 
 
porous scaffolds with the right level of porosity and pore interconnectivity, thus being very 
promising in tissue engineering approaches.
57,19
   
 
Figure 6. Structure of PLGA.  
Due to its excellent properties, PLGA is approved by the European Medicine Agency as 
well as by the US Food and Drug Administration. It is also used in other biomedical applications 
aiming at tissue regeneration such as drug and gene delivery.  
 
1.4. Poly(amidoamine) (PAMAM) dendrimers 
Dendrimers are molecules with a special geometry as they grow radially from a central core, 
generation by generation, forming star-like structures (Figure 7). They have three distinct parts: 
the core, the central shell and the outer groups.
58
 As the generation of the dendrimer grows, the 
12 
 
dendrimer starts to adopt a spherical shape.
59
 There are two well established possible ways for 
the synthesis of dendrimers, namely convergent and divergent methods.
60
 In the divergent   
method, the synthesis starts from the core of the dendrimer and proceeds outwards. In the      
convergent method, the dendrimer branches are first synthesized and then step-by-step           
assembled from the periphery towards the core of the final dendrimer. One important             
characteristic of dendrimers is that they have cavities in their interior (that, for instance, can be 
used to accommodate drugs) and a high number of terminal (surface) groups that can be       
functionalized (for carrying drugs or for linkage to specific chemical compounds that allow cell 
targeting).
61
 Furthermore, in comparison to the classical polymers, the dendrimers have a      
well-defined shape and molecular weight (low polidispersity). For these reasons, dendrimers 
have been studied for a wide range of biological and medical applications (drug delivery, gene 
delivery, bioimaging, etc.).
62,63  
The poly(amidoamine) (PAMAM) dendrimers are the most studied dendrimers for       
biomedical applications.
64
 Native PAMAM dendrimers have primary amines at their surface and 
tertiary and secondary (amides) amines in their interior. At the physiological pH, these          
dendrimers are positively charged and can interact with anionic molecules. In gene delivery  
studies, a plasmid DNA (pDNA) that codifies a certain bioactive protein may be complexed with 
PAMAM dendrimers and thus form dendriplexes.
65
 Being negatively charged, the pDNA alone 
has difficulties in penetrating the membrane of cells that also possesses a negative charge due to 
the glycoproteins at their surface. In dendriplex formation, the charge of the pDNA molecule is 
neutralized and the molecule is compacted, thus favoring DNA uptake by cells.
66
 It is reported 
that the efficiency of transfection mediated by dendrimers is generation and cell type dependent. 
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Figure 7. Schematic diagram of a generation 3 poly(amidoamine) (PAMAM) dendrimer. Note 
the presence of the functional end groups at the perifery. Adapted from ref. 
67
. 
Dendrimers can even be functionalized at the surface to diminish their cytotoxicity (cationic 
dendrimers can be particularly toxic) or to specifically interact with cell surface receptors and 
facilitate the cell uptake process.
68
 Indeed, numerous studies showed the efficacy of dendrimers 
as drug delivery vectors.
69
   
 
1.5. Human mesenchymal stem cells (hMSCs) 
Stem cells are cells that have the ability to regenerate themselves and to differentiate into       
different types of cells.
70
 Stem cells exist in the embryo and also in the adult organism where 
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they participate in the regeneration of tissues and organs (hence, they can be termed as “cells 
giving life to particular organs”).71,72  
Because they have a wide ability for differentiation, stem cells have a particular interest 
in tissue engineering. For this purpose, autologous, allogeneic or xenogenic cells can be used. 
However, autologous cells are, in principle, more appropriated to be implanted in the human 
body as they don´t give rise to immunological reactions.
73,74
 As such, stem cells can be removed 
from a patient, be propagated in vitro and then be used in tissue engineering constructs. 
Mesenchymal stem cells (MSCs) are multipotent stem cells that can be obtained from the 
adult (without raising ethical concerns) and that, upon certain stimuli, can differentiate into    
several cell types, like adipocytes, chondroblasts, and osteoblasts.
75
 These cells have also the 
advantage of proliferating very well in vitro and of being immunosuppressive (as such, cells 
from a different individual can be used in a patient).
76
 Human mesenchymal stem cells (hMSCs) 
are thus very promising for tissue engineering, in particular for bone tissue engineering.  
In order to differentiate into the desired cell type, the mesenchymal stem cells must be 
submitted to specific stimuli that can be of biochemical nature. Dexamethasone, for instance, is 
often use in vitro to induce the differentiation of MSCs into bone forming cells (osteoblasts).
77
 
Bone morphogenetic protein-2 (BMP-2) is also known for its ability to direct MSCs               
differentiation towards the osteoblastic lineage both in vitro and in vivo.
78
 When bioactive     
proteins are used to direct MSCs differentiation, one should consider two possibilities: to use the 
protein itself or to use the gene codifying the protein.
79
 The use of genes instead of proteins   
presents an important advantage. Indeed, as proteins easily denaturate and lose their activity, a 
high quantity must be used which can cause side effects in the body, whereas when genes are 
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used, the cells will produce the proteins at a physiological concentration. Indeed, a study by  
Santos et al. showed that it is possible to deliver the BMP-2 gene into MSCs using PAMAM 
dendrimers as gene delivery vectors to differentiate the cells into osteoblasts. This study further 
showed that a low transfection level may be sufficient to accelerate cell differentiation as cells 
will after communicate among them through paracrine mechanisms. Hence, it is possible to take 
the patient’s own stem cells, genetically modify them in vitro and then implant them in the body 
attached to a scaffold. Alternatively, a bioactive scaffold can be used, from where genes         
codifying growth/differentiation factors will be release and transfect the stem cells existent in the 
body which will be recruited for the implant site. This second approach has the disadvantage that 
other types of cells can be transfected. 
 
1.6. Objectives of the thesis 
This master project aimed to study the possibility of using poly(lactic-co-glycolic acid) (PLGA) 
electrospun fiber mats as vehicles for gene delivery into human mesenchymal stem cells 
(hMSCs) having in view applications such as bone tissue engineering. Complexes of PAMAM 
dendrimers and plasmid DNA (codifying the bone morphogenetic protein-2, BMP-2) were    
immobilized in the electrospun fiber mats using polymers with opposite charges (chitosan and 
alginate) and the layer-by-layer (LbL) technique. hMSCs were then cultured in the gene-loaded 
electrospun fiber mats and their proliferation and differentiation towards the osteogenic lineage 
was evaluated. 
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In more detail, the project aimed: 
a) The preparation of PLGA fiber mats using the electrospinning technique and their            
characterization by Scanning Electron Microscopy (SEM) and Contact Angle measurement; 
b)  The evaluation of the possibility of using chitosan and alginate as polymers for the coating 
of the PLGA fiber mats using the LbL technique; this was done using Fluorescence        
Spectroscopy; 
c) The study of the ability of PAMAM dendrimers (generation 5) to compact pDNA through the 
PicoGreen
®
 assay (pDNA/dendrimer complex formation); 
d) The determination of the capacity of the coated PLGA fiber mats to load pDNA/dendrimer 
complexes; for this, the PicoGreen
® 
assay was also used; 
e) The study of the cumulative release of pDNA along time from the coated PLGA fiber mats; 
for this, the electrostatic interaction between the pDNA and the PAMAM dendrimers was 
disrupted and the amount of pDNA was obtained using the  PicoGreen
®
 assay; 
f) The evaluation of the cell adhesion and cell proliferation on non coated and coated PLGA 
fiber mats; this was done using NIH 3T3 cells and the resazurin reduction assay;  
g) The evaluation of the transfection efficiency using a pDNA codifying the luciferase enzyme 
and NIH 3T3 cells cultured on coated PLGA fiber mats; 
h) The study of the proliferation and differentiation of hMSCs cultured over the coated PLGA 
fiber mats loaded with pDNA codifying for the BMP-2 protein.  
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CHAPTER 2 
EXPERIMENTAL PART 
2.1. Materials, reagents and cell culture media 
Poly (D,L-lactide-co-glycolide) (PLGA) (MW = 71,000, 1.25 g/cm
3
, IV = 0.59 dl/g was bought 
from Jinan Daigang Company (China). Sodium alginate (ALG) (MW = 50-120kDa), chitosan 
(CHI, from crab shells, 85% deacetylated), tetrahydrofuran (THF), dimethylformamide (DMF), 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), and N-Hydroxysuccinimide (NHS) 
were purchased from Sigma-Aldrich
®
. Poly(amidoamine)    (PAMAM) dendrimers, generation 5, 
with amino termini and an ethylenediamine core (G5) were acquired to Dendritech Inc. (USA). 
The dialysis membranes were from Spectrum
®
 Laboratories and the filters used for sterilization 
(0.22µm) were from VWR
®
. The Quant-iT™ PicoGreen® dsDNA Kit was from Invitrogen®. The 
experiments also used: phosphate buffer saline solution (PBS; Gibco
®
, without calcium or   
magnesium), Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma-Aldrich®), -Minimum 
Essential Medium (-MEM; Gibco®), trypsin-EDTA solution (0.05% w/v, Gibco®), ascorbic 
acid (Sigma-Aldrich
®
), beta-glycerophosphate (Sigma-Aldrich
®
), dexamethasone (Sigma-
Aldrich
®
), Reporter Lysis Buffer (RLB, Promega
®
), luciferase assay system (Promega
®
),        
bicinchoninic acid assay (BCA, Sigma-Aldrich
®
), sodium chloride (Merck
®
), sodium carbonate 
(Merck
®
), sodium bicarbonate (Merck
®
), magnesium chloride (Sigma-Aldrich
®
), p-nitrophenyl 
phosphate (Sigma-Aldrich
®
), acetic acid (Riedel-de Haen
®
), rhodamine B (Gibco
®
), and         
fluorescein isothiocyanate  (FITC, Sigma-Aldrich
®
).  
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2.2. Preparation of PLGA mats by electrospinning  
 
A PLGA (27.5% w/v) polymer solution was prepared by dissolving the PLGA solid in            
tetrahydrofuran (THF)/dimethylformamide (DMF) (3/1) solvent mixture.
80
 The solution was left     
overnight for homogenization protected from light.  
The homogenized PLGA polymer solution was fed into the syringe of the electrospinning 
equipment (FM1108, Beijing Future Material Sci-tech Co. Ltd, Ad. ZhongGuancun, Beijing 
P.R.China, Figure 8) and a high voltage (20 kV) was applied to the polymer solution. During this 
process, a charged jet was ejected from the needle and then undergone extensive stretching and 
thinning along with a rapid solvent evaporation. The distance between the needle tip to the    
collector plate was 15cm. While the jet traveled towards the grounded collector, the fibers were 
formed and collected on the aluminium foil (Figure 9). The fibrous mats were dried in the       
desiccator for a complete evaporation of the solvent (usually 2 days) and detached from the foil 
before use. The experimental conditions used in the electrospinning process are summarized in 
Table 1. 
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                                          Figure 8. Electrospinning equipment. 
 
 
Figure 9. Electrospinning equipment (magnification of the internal constituents). 
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Table 1. Parameters used in the preparation of the electrospun PLGA fibers. 
CONDITIONS USED 
Concentration of PLGA  27.5% 
Collecting distance 15 cm 
Syringe  1 ml 
Nozzle size  8 mm 
Voltage  +20 kV / -2.50 kV 
Flow rate  0.004 mm/s 
Relative Humidity  (%)  38 to 40 
 
 
2.3. Characterization of the electrospun PLGA fibers 
2.3.1. SEM analysis of the electrospun mats  
The morphology of the PLGA fibers was analyzed by scanning electron microscopy (SEM, 
JEOL, JSM-5600LV).
81
 Before SEM observations, the samples were sputtered with gold (a film 
with a thickness of 10 nm was formed in their surfaces). The fiber diameters were measured  
using the Image J 1.40G software. 
 
2.3.2. Porosity of the electrospun mats  
The porosity of the electrospinning fibrous mats was calculated according to the following   
equations:
81
  
ρ(g/cm3)= m(g) ÷ d(cm) × s(cm2) 
 
Porosity (%) = (1− ρ/ρo) × 100% 
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where ‘ρ’ is the apparent density of the electrospun scaffold, ‘m’ is the mass of the fiber, ‘d’ is 
the thickness of the scaffold, ‘s’ is the area of the electrospun scaffolds, and ρo is the density of 
the bulk polymer PLGA, which is 1.25 g/cm.
3,82
 The electrospun fibrous mats were cut into 20 x 
20 mm (8 samples) for these experiments. Each sample was weighed individually and it’s   
thickness was measured using the Vernier calipers (Trade Tools Ltd., China). To enhance the 
accuracy of the fiber thickness, all the 8 samples of the fiber mats were placed together in the 
same position and then the thickness was measured from the side corners, middle. Together with 
the area of the sample fibrous mats, these parameters were applied in the above mentioned   
equation to determine the apparent density. Then, the obtained apparent density is applied in the 
second equation to determine the porosity.
83
  
 
2.3.3. Water contact angle (WCA) measurements  
The electrospun PLGA fibers were cut into 20x20 mm and placed on the sample platform of a 
Drop shape analyzer (KRUSS, DSA100).84 One sessile droplet of distilled water with 4L     
volume was dropped onto randomly selected areas for each sample at ambient temperature and 
humidity. The static values of the water contact angle were measured when the droplet was    
stable. At least four measurements on each film were averaged for data analysis.
85
 The Water 
contact angle was measured with DSA 100 Instrumental software.  
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Figure10. Drop shape analyser – Adopted from KRUSS, DSA100 software program. 
 
 
 
2.4. Preparation of chitosan and alginate solutions  
2.4.1 Preparation of pristine sodium alginate and chitosan solutions 
For the experiments, an alginate solution (1 mg/ml) was prepared in 0.15M NaCl. The pH of the 
alginate solution was adjusted to be 7.2 with 0.1M NaOH. A chitosan solution (1mg/ml) was also 
prepared. The chitosan powder was dissolved in 0.1M acetic acid and 0.15M NaCl. This solution 
was gently stirred overnight to become homogeneous. The pH of the chitosan solution was 3.4. 
This was not adjusted to physiological pH. 
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2.4.2. Preparation of rhodamine B labeled chitosan solution  
The conjugation of chitosan with rhodamine B was summarized in figure 11.
86
 Chitosan was 
dissolved in 20 ml of 0.1M acetic acid to prepare a 1% w/v chitosan solution and, in the next day, 
an equal volume of methanol was added. A rhodamine B solution was also prepared by          
dissolving 8 mg of the product in 4 ml of methanol. Before mixing with chitosan, rhodamine B 
was activated with a 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and                      
N-hydroxysuccinimide (NHS) mixture for 3 hours (the concentration of EDC and NHS was two 
folds the concentration of rhodamine B). Then, the activated Rhodamine B was added dropwise 
to the chitosan solution under vigorous stirring at room temperature, in the dark, for 3 days.   
After that, the resulting solution was adjusted with NaOH (0.5M) to pH=10 in order to           
precipitate the conjugated compound. Then the compound was transferred to 15 ml tubes and 
centrifuged for 10 minutes at 15000 rpm. The supernatant was removed and the pellet was 
washed using ultrapure water. This step was repeated until no fluorescence supernatant was    
detected (7 centrifugations were done). Once the centrifugation was completed, the precipitate 
was dissolved in 10 ml of 0.1M acetic acid again and dialysed against 0.1M acetic acid solution 
for 3 days, followed by lyophilization to get the rhodamine B-conjugated chitosan compound. 
For the stock solution, the compound was dissolved in the mixture solution of 0.1M acetic acid 
and 0.15M sodium chloride. The final solution concentration was brought to 1mg/ml before use.       
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Figure 11. Conjugation of chitosan with rhodamine B. 
 
2.4.3. Preparation of fluorescein isothiocyanate (FITC) labeled sodium alginate solution  
The conjugation of alginate with FITC was summarized in figure 12.
87
 An aqueous solution 1% 
w/v of sodium alginate was mixed with EDC/NHS (3:1) for the activation of the carbonyl groups 
on alginate in acetic acid buffer (pH 4.9) for 30 min, followed by addition of                           
hexamethylenediamine (60 mg) and reaction for another 4 h. The mixture was precipitated in    
2-propanol to remove the unreacted diamine. The alginate-amine derivative was then reacted 
with FITC (2 mg) in pH 9.0 sodium bicarbonate solution for 4 h and then dialyzed against     
distilled water for 2 days. The resulting alginate-FITC solution was lyophilized.  
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Figure12. Labeling of sodium alginate with FITC.  
 
For the stock solution, the alginate-FITC compound was dissolved in 0.15M sodium chloride. 
The final solution concentration was brought to 1mg/ml before use.     
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2.5. Surface functionalization of the PLGA fibers using the LbL technique  
The PLGA fiber mat produced using the electrospinning technique and deposited onto a          
aluminium foil was removed after drying and was cut into 1.5 x 1.5 cm
2
 for use. Before         
functionalization, the PLGA fiber mats were used as covers of glass coverslips and placed inside 
the wells of 24-well cell culture plates.
88
 The functionalization of the PLGA fibers with        
polyelectrolytes using the layer-by-layer approach was similar to what is described in the        
literature.
89-91
 In a typical procedure, the PLGA fibrous mats were first immersed into            
chitosan(1mg/ml) solution for 10 min, followed by rinsing with water three times (each rinsing 
step took 2 minutes). Then, the substrates were immersed in the negatively charged                
alginate(1mg/ml) solution for 10 min, followed by similar rinsing steps in water. The             
immersion/rinsing cycles were repeated until the desired number of bilayers was achieved.
92
 In 
this work, a bilayer is obtained after one deposition cycle (so, it consists in one layer of chitosan 
and one layer of alginate, by this order). Two bilayer-coated PLGA fibers were used in the     
experiments done in this thesis. 
The polyelectrolyte deposition process over the PLGA fiber mats was followed by       
fluorescence spectroscopy by using rhodamine B-labeled chitosan (excitation wavelength 540nm 
and emission wavelength 625nm) and FITC-labeled alginate (excitation wavelength 495nm and 
emission wavelength 519nm). To avoid possible crossing interferences in the absorption and 
emission processes, the study was first made with rhodamine B-labeled chitosan and pristine 
alginate. After, a similar study was done with pristine chitosan and FITC-labeled alginate. The 
fluorescence measurements were made using a microplate reader (Victor
3 
1420, Perkin Elmer). 
 
27 
 
 
 
Figure 13. Interaction between positive charged chitosan and negative charged alginate.
93
  
 
2.6. Plasmid propagation and isolation 
 
Two kinds of pDNAs were used in the present work: (a) a pDNA encoding luciferase (Luc) and 
enhanced green fluorescent protein (EGFP) (pEGFPLuc, 6.4 kb); (b) a pDNA encoding the bone 
morphogenetic protein-2 (BMP-2) (pcDNA3.1/Hist©/hBMP2, 8.5 kb, kindly donated by Prof. 
Yasuhiko Tabata, University of Kyoto, Japan). Both plasmids were amplified in Escherichia coli 
host strain, DH5, grown overnight in Luria-Broth Base medium containing ampicillin.         
Afterwards, the plasmids were isolated and purified using a Qiagen Plasmid Maxi Kit (Qiagen). 
The isolated plasmids were dissolved in a small amount of ultra-pure water and the concentration 
of plasmid DNA in solution was determined from the UV absorbance at 260 nm.
94
 For          
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evaluation of plasmid purity, the absorbance ratio at 260nm and 280nm was measured and was 
always found to be in the range of 1.7 and 1.9.  
 
2.7. Dendrimer/pDNA complex assembly  
Dendrimer/pDNA complexes were prepared at several N:P ratios (where N= number of 
primary amines in the conjugate; P= number of phosphate groups in the pDNA backbone) by 
mixing adequate volumes of a solution of poly(amidoamine) (PAMAM) dendrimers (G5,       
generation 5, with amino termini and an ethylenediamine core) (1mg/ml) and a pDNA solution 
(0.1µg/µl).
95
 PBS solution (pH= 7.4) was always used to prepare these solutions. Complex     
solutions were vortexed and allowed to incubate for 20 minutes at room temperature prior to 
experiments. The N:P ratios selected to study pDNA compactation were 0, 0.5, 1, 2, 4, 6 and 8, 
respectively. The N:P ratio used when pDNA was immobilized in the electrospun fiber mat was 
5. At this ratio, the size of the complexes was measured at 633 nm on a dynamic light scattering 
instrument (Zetasizer Nano ZS, Malvern Instruments) using a detection angle of 173°. Zeta    
potential measurements were also performed using a detection angle of 17° and were calculated 
using the Smoluchowsky model for aqueous suspensions. The data presented are means of three 
independent measurements. 
 
2.8. PicoGreen® intercalation assay  
The ability of the dendrimers to compact pDNA was studied using the PicoGreen® assay.
96
 
PicoGreen
® 
is a fluorescent dye that emits light when bonded to double strand DNA. When the 
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DNA is completely free in solution, the intensity of the fluorescence attains a maximum level. 
When the DNA is compacted due to complexation with the dendrimer, PicoGreen
®
 cannot bind 
DNA and the fluorescence intensity decreases.  
PicoGreen
®
 was diluted 200x in Tris-EDTA buffer (10mM Tris, 1mM EDTA, pH = 7.5) 
according to the manufacturer’s instructions. Then, 100 μl of this solution was added to 100µl of 
each dendrimer/pDNA complex solution. The resultant mixture was incubated for 5 minutes at 
room temperature in the dark. The resultant mixture was then transferred to a 96-well plate and 
PicoGreen
®
 fluorescence was measured using a microplate reader (Victor
3 
1420, Perkin Elmer) 
at excitation wavelength 485nm and emission wavelength 535nm. A blank was prepared with 
100µl of PBS and 100µl of the diluted PicoGreen
®
 solution. Three independent experiments 
were performed and the % of relative fluorescence (%F) was determined using the following 
equation: 
%F = 100


blankDNAonly
blanksample
FF
FF
 
The fluorescence from free DNA was considered to be 100% (N:P ratio 0).  
 
2.9. Immobilization of the pDNA/dendrimer complexes on the PLGA fiber mats  
Fiber mats without and with polyelectrolyte coverage (2BL, 2 bilayers of CHI/ALG polymers) 
were used in the experiments. The desired amount of dendrimer/pDNA complex (N/P=5, pDNA 
= 1µg/well or 2µg/well) was dispersed in 400µl PBS solution and added to each well of a        
24-well plate containing the fiber mats, followed by 30 min incubation at room temperature. The 
amount of dendrimer/pDNA complex loaded on the PLGA fiber mats was indirectly determined 
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by measuring the quantity remaining in solution. For that, 100µl of the gathered supernatant was 
added of an equal volume of sodium alginate solution (6mg/ml) and shaked gently for 1 h (37°C, 
217 rpm/min) to disrupt the electrostatic interactions between the dendrimer and the pDNA. 
Then the amount of pDNA in solution was quantified using the PicoGreen
®
 assay. For the    
quantification, a calibration curve was constructed using a series of pDNA standard solutions 
with increasing concentrations, in the presence of sodium alginate (6mg/ml).  
 
2.10. pDNA/dendrimer complex release from the PLGA fiber mats   
After loading the fiber mats with the complexes and quickly rinsing with ultrapure water to   
remove the non-bonded complexes, 400µl PBS solution was added to each well and the release 
of the complexes was studied over a period of 24 h.
97
 The experiments were conducted at 37°C, 
under shaking. An initial load of 2ug/well pDNA was used in each well. Samples were taken at 
different time intervals and analyzed using the PicoGreen
®
 assay after disruption of the         
electrostatic forces existent between the dendrimers and the pDNA, and using the methodology        
described in the previous section.  
 
2.11. Biological assays 
2.11.1. Cells and cell culture 
The main equipment used in the biological assays was a CO2 incubator (Nuaire, AutoFlow IR 
Direct Heat), a laminar flow chamber (Nuaire, Class II A/B3), an inverted optical microscope 
(Olympus, CK40), an inverted fluorescence microscope (NIKON, TE2000), and a microplate 
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reader (PerkinElmer, Victor3
TM
). All cell culture dishes were from NUNC. All cell cultures were 
incubated at 37°C, in a humidified atmosphere of 95% air and 5% carbon dioxide. NIH 3T3 cells 
(a cell line derived from primary mouse embryonic fibroblasts) were cultured in DMEM (Sigma-
Aldrich
®
) and hMSCs were cultured in -MEM (Gibco®) supplemented with 10% fetal bovine 
serum (FBS; Gibco
®
) and 1% of an antibiotic-antimycotic solution (Gibco
®
, with 10,000 units 
penicillin/ml, 10 mg streptomycin/ml and 25µg amphotericin B/ml). The primary cultures of 
hMSCs were established from small pieces of human trabecular bone rich in bone marrow which 
were obtained from patients during surgery interventions after trauma. Only bone that would 
have been discarded was used, with the approval of the Dr. Nélio Mendonça Hospital (Funchal 
main hospital) ethics committee. The trabecular bone was kept in sterilized tubes, refrigerated, in 
-MEM supplemented with 10% FBS and 1% antibiotic–antimycotic solution, for 3 to 4 h. 
Then, primary cultures were prepared by gently shaking the tubes with the bone marrow pieces 
to obtain a cell suspension, which was spread by cell culture dishes. The culture medium was 
removed and changed by new one after 1 day to remove the non-adherent hematopoietic cells.  
The medium was always changed twice a week until confluence was achieved. The cultures were 
then passaged and frozen in liquid nitrogen using the standard procedure.  
Cell passages were always done using trypsin (0.05% w/v) and following the standard 
protocol. The media and solutions used in the cell culture assays were prepared as follows. 
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Dulbecco’s Modified Eagle’s Medium (DMEM) 
A stock solution of DMEM was prepared by adding the commercial DMEM powder and       
NaHCO3  to distilled water following the instructions present in the DMEM bottle label. The pH 
of this solution was first adjusted to 7.4 using 1M NaOH or 1M HCl solution and the medium 
was then sterilized by filtration (0.22µm filter). Complete DMEM (250ml) medium was prepared 
by mixing 25 ml (10% v/v) of FBS, 2.5 ml of antibiotic solution (1% v/v) and 222.5ml of 
DMEM (stock). The fresh complete DMEM solution was kept refrigerated at 4
0
C before use.  
 
-Minimum Essential Medium (-MEM) 
A stock solution of -MEM was prepared by adding the commercial -MEM powder and     
NaHCO3 to distilled water following the instructions present in the -MEM bottle label.  The pH 
of DMEM solution was first adjusted to 7.4 using 1M NaOH or 1M HCl solution and then     
sterilized by filtration (0.22µm filter). Complete -MEM (200ml) medium was prepared by   
mixing 20ml of FBS (10% v/v), 2ml of the antibiotic-antimycotic solution (1% v/v), and 178ml 
-MEM stock solution.  The fresh complete -MEM solution thus prepared was kept             
refrigerated at 4
0
C before use. For osteogenesis induction, the complete -MEM medium was 
further supplemented with ascorbic acid (250µM), beta-Glycerophosphate (5mM), and           
dexamethasone (10
-9
 M). 
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Phosphate buffer saline (PBS) 
 
The phosphate buffer saline (PBS) solution was prepared by dissolving 9.55g of PBS powder in 
1L of distilled water. The pH of PBS solution was first adjusted to 7.4 using 1 M NaOH or 1 M 
HCl solution and then sterilized by filtration (0.22µm filter). 
 
2.11.2. Cell attachment and proliferation on PLGA fiber mats  
Cell attachment and proliferation on the PLGA electrospun mats was evaluated using NIH 3T3 
cells directly cultured on the electrospun PLGA fibrous mats.
98
 The mats were cut, mounted on  
circular glass cover slips (diameter of 14 mm) and then fixed in 24-well plates. For sterilization, 
the mats were initially left under UV radiation overnight, followed by soaking with 75% ethanol 
solution for 1.5 h and, ultimately, washed three times with PBS solution. The electrospun mats 
were then soaked in culture medium overnight prior to cell seeding. For the cell attachment and 
proliferation experiments, NIH 3T3 cells were detached from the culture dish using                
trypsin-EDTA solution (0.05% w/v) and seeded on the top of the mats at a concentration of 
2×10
4
 cells/well. Both fiber mats with and without polyelectrolyte coverage (2BL, 2 bilayers of 
CHI/ALG polymers) were used in the experiments. Control experiments were conducted with 
cells cultured directly on the plastic surface of the cell culture dishes and on the glass surface of 
the coverslips.  
               Cell adhesion was evaluated at 1 h, 3 h, and 6 h of cell culture. Cell proliferation was 
studied from 1 day until 7 days in culture. Cell adhesion/proliferation was studied based on the 
resazurin reduction cell metabolic assay.  The resazurin reagent was prepared by mixing 0.02g of 
resazurin with 200ml of PBS solution (resazurin stock solution). This solution was sterilized with 
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a 0.22µm membrane inside the laminar flow hood chamber. The prepared resazurin solution was 
distributed into small tubes and stored at -20
0
C. At the appropriate time point, the medium in 
each cell culture well was replaced by fresh medium (1ml) containing 10% v/v of resazurin stock 
solution and the cells were further incubated for 3 h. Subsequently, 100µl of the resultant        
medium was transferred to 96-well plates (white, FluoroNunc
®
 96 well plates) and the resorufin 
fluorescence (ex= 530nm, em= 590nm) was measured in the microplate reader. All experiments 
were conducted in triplicate. Blank experiments were done using wells containing PLGA       
electrospun mats but without seeded cells. 
 
 
2.11.3. In vitro gene transfection study using a pDNA encoding luciferase (Luc)  
The preparation, sterilization and pDNA/dendrimer complex (prepared with the pEGFPLuc 
plasmid) loading of the PLGA fibrous mats were performed according to the procedures already 
mentioned. In these studies, NIH 3T3 cells (2×10
4
 cells/well) were seeded in the wells of 24-well 
plates containing pDNA/dendrimer-loaded fibrous mats, with and without polyelectrolyte       
coverage. Control experiments were performed using fibrous mats samples without 
pDNA/dendrimer-loading, with and without polyelectrolyte coverage (2 bilayers). Another     
control experimented consisted in cells directly cultured on the glass surface of the cover slips. In 
all cases, cells were allowed to grow for 48 h and then cell viability was measured (using the 
resazurin reduction method previously described) and further harvested for luciferase activity 
and total protein content analysis. During cell harvesting, cells were first washed once with PBS 
solution, and then 100µl of lysis buffer (1x, Reporter Lysis Buffer, Promega) was added to each 
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well. Homogenized cell lysates were obtained after three cycles of freezing (-20°C, 20 
min)/thawing (room temperature, 90 rpm shaking). Cell lysates were transferred to an eppendorf 
for luciferase and protein analyses. Luciferase activity in cell lysates were measured using the 
Promega’s luciferase assay reagent (the supplier’s instructions were followed).99 For each sample, 
the microplate reader was set for 3 s delay with signal integration for 10 s. The amount of protein 
in cell lysates was determined using the bicinchoninic acid assay (BCA assay) using bovine   
serum albumin as a standard.
99
  
 
 
2.11.4. In vitro gene transfection study using a pDNA encoding the bone morphogenetic 
protein-2 (BMP-2)  
These experiments were very similar to those described in the previous subsection but used 
hMSCs (passage 3) and a pDNA encoding the bone morphogenetic protein-2 (BMP-2) 
(pcDNA3.1/Hist©/hBMP2). Also, cell culture was performed along 21 days. For these            
experiments, -MEM containing ascorbic acid (250 µM) and  beta-glycerophosphate (5mM) was 
used. Osteogenesis positive control experiments were also conducted using dexamethasone in the 
cell culture medium (10
-9
 M).
100
 For all cases, the medium was replaced every 3 days and cells 
were incubated at 37°C in a humidified atmosphere with 5% CO2. 
 Cell viability was analyzed after 14 days of cell culture using the resazurin reduction   
assay. Alkaline phosphatase (ALP) activity was measured after 14 and 21 days of culture, as well 
as the total protein content (BCA assay). The hMSCs were first rinsed 3 times with PBS. Then, 
200 µl of Reporter Lysis Buffer was added to each well and homogenized cell lysates were    
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obtained after three cycles of freezing (-20°C, 20 min)/thawing (room temperature, 90 rpm   
shaking). Cell lysates were stored at -20°C for further analysis. Alkaline phosphatase (ALP)  
activity was determined using a colorimetric assay involving the hydrolysis of p-nitrophenyl 
phosphate to p-nitrophenol (yellow). Briefly, 20 µl of the cell lysates were mixed with 200 µl of 
ALP substrate and incubated for 1 h at 37°C in the dark. Then, 10 µl of 0.02M NaOH was added 
to each well to stop the hydrolysis reaction. The absorbance was read at 405 nm and the             
p-nitrophenol content was calculated from a standard calibration curve. The results are presented 
using arbitrary units but express the number of moles of p-nitrophenol produced by unit of time 
and by µg of protein. 
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CHAPTER 3.  
RESULTS AND DISCUSSION  
3.1. Preparation and characterization of the electrospun PLGA fibers  
Fiber mats made of poly (L-lactic-co-glycolic acid) (PLGA) were successfully prepared using 
the electrospinning technique and experimental conditions reported in the literature. Indeed, the 
polymer solution properties and the electrospinning processing parameters are of vital            
importance for the surface and mechanical properties of the electrospun fibers, as well as for 
their uniformity.
101
 Figures 14A and 14B show the morphology of the obtained electrospun fiber 
mats after visualization by scanning electron microscopy (SEM). We can observe that the mats 
mainly consist in fibers with diameters in the micrometer range.  
The porosity of the fiber mats was also experimentally determined and, as expected, its 
value was very high (97.47±0.05%). Thus, this indicates that the mats should be appropriate for 
tissue engineering applications since cells can growth inside the pores.  Furthermore, by detailed 
analysis of the SEM images, one can conclude that the pores are interconnected, which is a very 
important requirement in tissue engineering.  
The PLGA fiber mats were also characterized by contact angle measurement to evaluate 
its wettability properties which can strongly determine the interactions of a surface with         
biomolecules and cells. The contact angle was found to be 115
0
±5
0
, which indicates that the 
PLGA fiber mat surface is relatively hydrophobic. This is in accordance with the literature     
data.
102
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Figure 14. SEM images of electrospun PLGA fiber mats before (A and B) and after the          
deposition of a bilayer of 2 polyelectrolytes (C and D). B and D are the magnified images of A 
and C, respectively. 
 
3.2. Modification of the electrospun PLGA fiber mats with polyelectrolytes using the 
LbL technique  
As a mean of immobilizing the pDNA/dendrimer complexes (that are positively charged),
103
 the 
surface of the electrospun fiber mats was modified using the LbL technique and chitosan        
(cationic) and alginate (anionic) as oppositely charged polyelectrolytes. Each bilayer consisted in 
the deposition of a first layer of chitosan and a second layer of alginate. After coating the surface 
A 
D C 
B 
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of the PLGA fiber mats with two polyelectrolyte bilayers, no significant change was observed in 
their morphology (Figure 14C and D). However, the contact angle decreased in some extent   
(Table 2) in relation to non-coated fiber mats as polyelectrolyte deposition enhanced the         
wettability of the surface due to the charged nature of the polyelectrolytes. On the other hand, 
there was no significant change in the contact angle with the increase of the number of         
polyelectrolyte bilayers deposited onto the mats. 
 
    
                                          A                                                                                         B 
Figure 15. (a) Fluorescence intensity of PLGA fiber mats coated with rhodamine B-labeled     
chitosan/alginate as a function of the number of bilayers; (b) Fluorescence intensity of PLGA 
fiber mats coated with chitosan/FITC-labeled alginate as a function of the number of bilayers.  
 
The success of the LbL process was confirmed by performing independent experiments 
with rhodamine B-labeled chitosan plus pristine alginate (Figure 15A), and pristine chitosan with 
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FITC-labeled alginate (Figure 15B). It is obvious that the fluorescence intensity increased with 
the number of polyelectrolyte bilayers (a linear increase was even observed when rhodamine B-
labeled chitosan was used), which demonstrates the successful coating of the PLGA fiber mats 
using the LbL technique.  
 
Table 2. Water contact angle of non-coated and coated PLGA electrospun fiber mats.  
Note: Random areas of the fiber mats were analyzed and the average value is indicated. 
Number of bilayers Water contact angle 
0 115
0 
± 5
0
  
1 106
0 
± 11
0
 
2 101
0
 ± 10
0
 
3 106
0
 ± 6
0
 
 
 
3.3. pDNA/dendrimer complex immobilization and release from the electrospun 
PLGA fiber mats 
PAMAM dendrimers with amino termini (G5, generation 5) have been shown to efficiently bind 
pDNA through electrostatic interactions since they are positively charged at the physiological 
pH.
104
 These molecules have the ability to neutralize the charge of the pDNA and also of      
compacting it. In fact, these dendrimers have a high density of surface active amines that make 
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them good gene delivery carriers and, also, confer them buffering capabilities that help them to 
escape from the acidic endosomal compartments (through the known “proton-sponge effect”).105  
In the present work, the capacity of G5 PAMAM dendrimers to condense pDNA was 
confirmed (Figure 16A) by preparing the complexes at different N:P ratios and evaluating the 
amount of “free pDNA” using the PicoGreen® assay (this is a fluorescent dye that intercalates in 
the double helix of DNA). The results show that a maximum of pDNA compactation is achieved 
for N:P ratios higher than 4. As such, a N:P ratio of 5 was chosen for all the following            
experiments. At this N:P ratio, the hydrodynamic diameter and surface zeta potential of the   
complexes were experimentally determined in PBS solution, being 422 ± 20 nm and +6.5 ± 0.9 
mV, respectively. Indeed, it is reported that complexes of G5 PAMAM dendrimers and the same 
type of plasmid (pEGFPLuc, 6.4 kb), at the N:P ratio of 5, present a size around 80 nm and a zeta 
potential value higher than +25 mV.
106
 The differences between the present results and those 
found in the literature may be due to the different buffer used in the preparation of the complexes. 
What is important is to highlight the fact that, by being positive, these nanoparticles can be    
deposited on the top of the polyelectrolyte coated electrospun fiber mats that have alginate as the 
last deposited polymer.  
The complex loading efficiency of the electrospun fiber mats was studied for uncoated 
and coated samples and for two different initial pDNA concentrations in the wells (1 µg/well and 
2 µg/well). The loading process consisted in the incubation of the fiber mats with a solution    
containing the pDNA/dendrimer complexes for 30 min (this time period was optimized for       
maximum loading), followed by washing to remove the complexes in excess. The amount of 
pDNA present in the withdrawn solution was determined using the PicoGreen
®
 assay (after   
disrupting the electrostatic forces within the complex with alginate) and the quantity of loaded 
42 
 
pDNA was calculated by difference from the initial amount of pDNA (in a complexed form) 
added to the wells.  
 
 
A 
   
B                                                                                     C 
Figure16. Study of pDNA/dendrimer compactation at different N:P ratios (A), and amount of 
pDNA retained in the fiber mats (pDNA loading) as a function of the quantity of pDNA added to 
the wells (B,C); in C, the amount of pDNA retained is expressed as a percentage of  the quantity 
of pDNA added to the wells.  
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Figures 16B and 16C summarize these results, together with Table 3. From Figure 16B and   
Table 3, one can conclude that a higher quantity of pDNA/dendrimer complex was retained in 
the electrospun fiber mats when 2 µg of pDNA was added to each well. This probably means 
that there were still spaces available for adsorption at the surface of the mats when the 2 µg/well 
pDNA concentration was used. Also, when the 2 µg/well pDNA concentration was used, the 
amount of pDNA retained was higher for the coated electrospun fiber mats than for non-coated 
ones. This might be due to the stronger electrostatic adsorption between the negatively charged 
alginate at the surface and the positively charged dendrimer/pDNA complexes (6.5 ± 0.89 mV).   
Interestingly, the percentage of pDNA retained in the fibers in relation to the quantity initially 
added to the wells, was always around 50% (Figure 16C and Table 3) which may indicate that an 
equilibrium is established between the adsorbed complexes and the ones that are kept in solution. 
When the concentration of the pDNA solution increases from 1 µg/well to 2 µg/well, more   
complexes will adsorb to the mat surface but, still, the same proportion of complexes will remain 
in solution. Similar results were obtained by other authors that used polyethylenimine 
(PEI)/DNA complexes immobilized on tissue engineering scaffolds made of               
poly(lactide-co-glycolide).
107
  
Table 3. pDNA loading on PLGA fiber mats.   
 Amount of loaded pDNA per 
well 
% of the amount of pDNA 
added to the well 
Amount of pDNA added 
to the well 
1µg 2µg 1µg 2µg 
Non-coated PLGA mats 0.56 µg 0.85 µg 56 ± 8% 42 ± 10% 
Coated (2BL) Fiber 
PLGA mats 
0.57 µg 1.1 µg 57 ± 15% 55 ± 7% 
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Based on these results, a pDNA concentration of 2µg/well was always used to load the 
electrospun fiber mats in the following experiments. 
 
 
 
Figure17. Cumulative release of pDNA from non-coated and coated electrospun fiber mats in 
PBS solution, at 37ºC. 
Figure 17 shows the cumulative release of pDNA from the PLGA fiber mats with and 
without surface modification. These results were obtained by adding PBS solution to the       
complex loaded electrospun fiber mats and by following the amount of complex released using 
the PicoGreen
®
 assay (after disrupting the electrostatic forces within the complex with alginate).  
It was clear that pDNA release for the coated PLGA fiber mats occurred in a much more        
sustained manner when compared to the non-coated samples, especially in the time window of 
30 min to 6 h. This might be ascribed to the strong electrostatic interaction between the 
pDNA/dendrimer complexes and the negatively charged PLGA surface. After 24h, the amount of 
pDNA detected in solution decreased significantly for the non-coated samples whereas remained 
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constant for the coated ones. The results at this time point were surprising since higher values of 
pDNA were expected for both cases. Probably, these results can be explained as follows. After 
6h, the amount of complexes released from the non-coated samples almost reached the total 
amount initially loaded. So, these complexes will be a long time in solution, being more         
susceptible to electrostatic disruption and pDNA degradation (degraded pDNA will not be     
detected using the PicoGreen
®
 assay). On the other hand, the coated samples released the     
complexes at a slower rate and, as a consequence, the pDNA was protected from degradation for 
a longer period of time. Taken together, these in vitro results point out that the coated            
electrospun fiber mats will be more adequate as vehicles for the delivery of pDNA/dendrimer 
complexes due to their sustained release behavior and, thus, capability to protect the pDNA. 
 
3.4. Cell attachment and proliferation on PLGA fiber mats 
The ability of the non-coated and coated electrospun fiber mats to support the attachment and 
proliferation of cells was evaluated using NIH 3T3 cells (a fibroblast cell line) and the resazurin 
reduction assay. The resazurin reduction assay is based on the capacity of metabolic active cells 
(living cells) to transform the compound resazurin into resorufin which is fluorescent. The 
fluorescence intensity is, then, directly proportional to the cell metabolic activity and, thus, to the 
number of viable cells. It allows, thus, an indirect measure of cell attachment and proliferation 
over the fiber substrates.  
Figures 18A and 18B show the results of cell attachment as a function of time (until 6h of 
cell culture) and of the type of surface (cells were seeded on the top of the plastic surface of cell 
culture wells and coverslips, as well as on the top of non-coated and coated electrospun fiber 
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mats). Whereas in Figure 18A the cell attachment is represented by the fluorescence intensity of 
resorufin, in Figure 18B the cell attachment is plotted as a percentage of the metabolic activity 
shown by the cells cultured in the plastic surface of the cell culture wells. Apparently, cells     
attached better to the plastic surface of cell culture wells or glass surface of the coverslips (used 
as controls) then on the top of the fiber mats. However, these two types of surfaces are difficult 
to compare using dye-based assays since the fiber mats are susceptible to dye absorption.
108
 That 
is, the resorufin produced during the assay used for cell attachment quantification may be      
absorbed by PLGA fibers and, so, its fluorescence signal will be reduced. However, one can 
compare the non-coated and coated electrospun fiber mats which, in the present case, were 
shown to be able of supporting cell attachment without significant differences between them. 
The fluorescence intensity grew along the first 6 hours of cell culture revealing a progressive 
attachment process. Figures 19A, 19B also illustrate these findings.  
Similar results were obtained for cell proliferation. The quantitative data presented in 
Figures 18C and 18D show that cells were able to growth in number in the four substrates      
studied, at least until seven days in culture. However, at days 3 and 7, the number of cells present 
on the top of coated electrospun fiber mats was a little bit smaller than the number of cells      
present on the top of non-coated surfaces. Although this difference is very small, it was          
significant and is probably related with the electrostatic repulsion between the negative charge of 
the last alginate layer that is covering the PLGA fibers and the glycolipids and glycoproteins 
existent in the cell membranes which also have a negative charge.  
The observation of the cultures by microscopy techniques also showed a good coverage 
of the surfaces by NIH 3T3 cells after 3 days of culture (Figures 19C, 19D), corroborating the   
quantitative data obtained through the resazurin reduction assay.  
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                                                 A                                                                                     B 
   
     C                                                                                      D 
Figure 18.  NIH 3T3 cells attachment (A and B) and proliferation (C and D) on the plastic     
surface of the culture dishes, on the glass surface of the coverslips, and on non-coated and          
2 bilayer-coated electrospun fiber mats. The values represent means from 4 replicates ± S.E.M.. 
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Figure 19. Scanning electron microscopy images of NIH 3T3 cells on the non-coated electrospun 
fiber mats  (A,C) and 2-bilayer-coated electrospun fiber mats (B,D). Images were taken after 6h 
(A, B) and 3 days (C,D).  
 
3.5. In vitro gene transfection studies  
Two types of gene transfection studies were performed with polyelectrolyte coated (2 bilayers) 
and non-coated electrospun fiber mats.
109
 The first one used a pDNA encoding for the luciferase 
enzyme and NIH 3T3 cells (Figure 20). The second one used a pDNA encoding for bone      
morphogenetic protein-2 (BMP-2) and human mesenchymal stem cells (hMSCs) (Figure 21).  
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Transfection experiments using the luciferase reporter gene 
The transfection efficiency achieved by the pDNA coated electrospun fiber mats was assessed 
after 48h of cell culture. After this period, NIH 3T3 cells viability was not significantly different 
in the 4 different types of surface studied, that is, in pDNA/dendrimer complex coated and     
non-coated, and polyelectrolyte coated and non-coated electrospun fiber mats (Figure 20A).   
 
 
A 
 
B 
Figure 20. NIH 3T3 cells viability (A) and luciferase activity (B) after 48h of culture and for the 
pDNA/dendrimer complex non-loaded and loaded electrospun fiber mats. The values represent 
means from 4 replicates ± S.E.M.. 
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In respect to luciferase enzyme activity, as expected, the levels were significantly higher for the 
electrospun fiber mats coated with pDNA/dendrimer complexes than for the pDNA/dendrimer 
complex non-coated surfaces (used as controls). Furthermore, the level of luciferase activity was 
enhanced for the surfaces coated with polyelectrolytes as a mean of immobilizing the 
pDNA/dendrimer complexes (Figure 20B). These findings are in agreement with the previous 
results that revealed a slightly higher pDNA loading in this type of surfaces and also, a sustained 
release of the loaded pDNA which may be beneficial for its stability and cellular internalization. 
Indeed, the transfection efficiency achieved by polyelectrolyte coated electrospun fiber mats was 
about 1.5 times higher than that observed when the polyelectrolyte layers were not present. 
 
Transfection experiments using the BMP-2 gene 
Even if the levels of luciferase activity previously obtained were not impressive, it was           
hypothesized that they could be sufficient for a clinical relevant application (e.g., tissue          
engineering) such as the differentiation of hMSCs towards the osteoblastic lineage. The same 
methodology for cell transfection was generally followed although the time of the experiments 
has been extended having in consideration the lower growth rate of this type of cells and the 
characteristic behavior of the osteogenesis process occurring in vitro. As such, the cells were 
cultured along 21 days in the surface of the electrospun fiber mats loaded with pDNA/dendrimer 
complexes. For comparison, cells were also cultured in the top of the plastic surface of culture 
dishes or over the electrospun fiber samples in the presence of dexamethasone (positive control 
of osteogenesis) which is known to be an osteogenesis inductive factor.
110
 Experiments were 
further done without dexamethasone and without pDNA using hMSCs cultured in the top of the 
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plastic surface of the cell culture dishes or over electrospun fiber mats (these were considered 
negative controls of the osteogenesis process). 
hMSCS viability was analyzed at day 14 of cell culture (Figure 21A) using the resazurin 
reduction assay. These results showed that the presence of dexamethasone did not affect cell 
viability and, again, that cell viability was apparently higher when cells were cultured in the   
plastic surface of the culture dishes than when electrospun fiber mats were used. The justification 
for this finding is the same as presented before and has to do with the probable absorption of 
resorufin by the fibers.
108
 However, the different experiments that used electrospun fibers can be 
compared among them. In this case, one can conclude that cell viability was not significantly 
different in all situations under study. 
Alkaline phosphatase (ALP) activity was measured at days 14 and 21 after cell seeding. 
This parameter is well established as an early marker of the osteogenesis process in vitro and is 
known to present high values between 2 to 3 weeks of cell culture, before the occurrence of   
mineralization.
111
 In the present work, cells were lysed and ALP activity was determined in their 
extracts. The results were normalized for the total protein content to get an indication of the ALP 
activity per cell, that is, of the extent of cellular differentiation. Figure 21B reveals that hMSCs 
differentiation towards the osteoblastic lineage was generally enhanced in the experiments done 
in the presence of dexamethasone (positive control) when compared with those performed in its 
absence and in the absence of pDNA/dendrimer complexes (negative control, without            
differentiation factors). When pDNA/dendrimer complexes were immobilized in the electrospun 
fiber mats without polyelectrolyte coating, the values of ALP activity were higher than those of 
the positive control (with dexamethasone). However, when pDNA/dendrimer complexes were 
immobilized in the electrospun fiber mats with polyelectrolyte coating, the extent of ALP      
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activity stayed in the middle of the correspondent positive and the negative control. These results 
can be explained by the fact that dexamethasone is a biochemical factor that is immediately 
available in the cell culture medium whereas that does not happens with BMP-2 in the case 
where pDNA/dendrimer complexes are used. Indeed, BMP-2 will only be produced after     
complex internalization, release of the pDNA from the dendrimer, entry of pDNA in the cell 
nucleus, transcription of the gene, and translation of the mRNA into the active protein. It is, thus, 
a slower process but that is expected to have longer time biological effects (due to the sustained 
release of complexes by the fibers) and less side effects (in comparison to the use of massive 
quantities of differentiation factors or other drugs that can be used for the same purpose).       
Because complex release is faster in the electrospun fiber mats without polyelectrolyte coating, 
an enhanced ALP activity in respect to the positive control is observed for those samples.       
Interestingly, when analyzing the results obtained for the different positive controls, it seems that 
the simple presence of the polyelectrolytes in the electrospun fiber mats have a positive effect on 
differentiation.  So, even if complex release from polyelectrolyte coated electrospun fiber mats 
was slower, the positive effect on differentiation caused by the presence of the polyelectrolyte 
layers conducted to non-significant differences of ALP activity (at both days 14 and 21) between 
polyelectrolyte non-coated and coated substrates having immobilized complexes. In vivo,     
however, one should expect prolonged biological effects when polyelectrolyte coated            
electrospun fiber mats are used due to their sustained release properties. 
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A 
 
 
B 
Figure 21. hMSCs viability at day 14 (A) and alkaline phosphatase (ALP) activity at days 14 and 
21 (B) for pDNA/dendrimer complex non-loaded and loaded electrospun fiber mats, with and 
without polyelectrolyte coating. The values represent means from 4 replicates ± S.E.M.. 
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CONCLUSIONS 
As a general conclusion, the merging of the electrospinning and the LbL techniques constitutes a 
promising approach for the development of biologically active surfaces for biomedical           
applications, namely for tissue engineering.  
 In more detail: 
a) PLGA fiber mats were prepared using the electrospinning technique; their characterization 
by Scanning Electron Microscopy (SEM) revealed that the diameter of the fibers was in the 
micrometer range, and the water contact angle measurements showed that their surface was 
relatively hydrophobic. 
b) The electrospun fiber mats were successfully coated with several layers of chitosan and   
alginate using the LbL technique which decreased in a small extent the hydrophobic       
character of the surface and simultaneously allowed the immobilization of pDNA/dendrimer 
complexes. 
c) pDNA/dendrimer complex release from the polyelectrolyte coated electrospun fiber mats was 
controlled along the time, protecting the pDNA from degradation. 
d) The polyelectrolyte coated electrospun fiber mats supported the growth and attachment of 
cells; in addition, the presence of pDNA/dendrimer complexes in the surface of the fibers had 
no deleterious effect over cell viability. 
e) The polyelectrolyte coated electrospun fiber mats were able of serving as vehicles for the 
effective delivery of the BMP-2 gene, which resulted in the enhanced differentiation of 
hMSCs towards the osteoblastic lineage.  
55 
 
REFERENCES 
1.       Naderi, H.; Matin, M. M.; Bahrami, A. R., Review paper: critical issues in tissue 
engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J. Biomater. 
Appl. 2011, 26, 383-417. 
2. Santos, J. L.; Pandita, D.; Rodrigues, J.; Pego, A. P.; Granja, P. L.; Tomás, H., Non-viral 
gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue 
engineering and regeneration. Curr. Gene. Ther. 2011, 11, 46-57. 
3. Zhao, C.; Tan, A.; Pastorin, G.; Ho, H. K., Nanomaterial scaffolds for stem cell 
proliferation and differentiation in tissue engineering. Biotechnol. Adv. 2013, 31, 654-668. 
4. Chen, R.; Huang, C.; Ke, Q.; He, C.; Wang, H.; Mo, X., Preparation and characterization 
of coaxial electrospun thermoplastic polyurethane/collagen compound nanofibers for tissue 
engineering applications. Colloids Surf. B. Biointerfaces. 2010, 79, 315-325. 
5. Pramanik, S.; Pingguan-Murphy, B.; Abu Osman, N. A., Progress of key strategies in 
development of electrospun scaffolds: bone tissue. Sci. Technol. Adv. Mater. 2012, 13, 1-13. 
6.       Puppi, D.; Zhang, X.; Yang, L.; Chiellini, F.; Sun, X.; Chiellini, E., Nano/microfibrous 
polymeric constructs loaded with bioactive agents and designed for tissue engineering 
applications: A review. J. Biomed. Mater. Res. Part : Appl. Biomater. 2014, 102, 1562-1579 . 
7. Karageorgiou, V.; Kaplan, D., Porosity of 3D biomaterial scaffolds and osteogenesis. 
Biomaterials 2005, 26, 5474-5491. 
8. Kievit, F. M.; Florczyk, S. J.; Leung, M. C.; Veiseh, O.; Park, J. O.; Disis, M. L.; Zhang, 
M., Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment. 
Biomaterials 2010, 31, 5903-5910. 
56 
 
9. Wang, X.; Ding, B.; Li, B., Biomimetic electrospun nanofibrous structures for tissue 
engineering. Mater. Today 2013, 16, 229-241. 
10. Teo, W. E.; Ramakrishna, S., A review on electrospinning design and nanofiber 
assemblies. Nanotechnology 2006, 17, R89. 
11. Bhardwaj, N.; Kundu, S. C., Electrospinning: a fascinating fiber fabrication technique. 
Biotechnol. Adv. 2010, 28 , 325-347. 
12.     Liu, H.; Ding, X.; Zhou, G.; Li, P.; Wei, X.; Fan, Y., Electrospinning of Nanofibers for 
Tissue Engineering Applications. J.  Nanomater. 2013, 2013, Article ID 495708. 
13.      Tucker, N.; Stanger, J. J.; Staiger, P. M.; Razzaq, H.; Hofman, K., The History of the Sci-
ence and Technology of Electrospinning from 1600 to 1995.  JEFF. 2012, 7 (Spec. Ed.), 63-72. 
14. Wu, J.; Wang, N.; Zhao, Y.; Jiang, L., Electrospinning of multilevel structured functional 
micro-/nanofibers and their applications. J. Mater. Chem. A  2013, 1, 7290-7305. 
15. Haynie, D. T.; Khadka, D. B.; Cross, M. C., Physical Properties of Polypeptide 
Electrospun Nanofiber Cell Culture Scaffolds on a Wettable Substrate. Polymers 2012, 4, 1535-
1553. 
16. Garg, K.; Bowlin, G. L., Electrospinning jets and nanofibrous structures. 
Biomicrofluidics 2011, 5, 1-19. 
17. Wang, H.-S.; Fu, G.-D.; Li, X.-S., Functional Polymeric Nanofibers from Electrospinning. 
Recent Pat. Nanotechnol. 2009, 3, 21-31. 
18. Chronakis, I. S., Novel nanocomposites and nanoceramics based on polymer nanofibers 
using electrospinning process - A review. J. Mater. Process. Technol. 2005, 167, 283-293. 
57 
 
19. Meng, Z. X.; Wang, Y. S.; Ma, C.; Zheng, W.; Li, L.; Zheng, Y. F., Electrospinning of 
PLGA/gelatin randomly-oriented and aligned nanofibers as potential scaffold in tissue 
engineering. Mater. Sci. Eng. C 2010, 30, 1204-1210. 
20. Pham, Q. P.; Sharma, U.; Mikos, A. G., Electrospinning of polymeric nanofibers for 
tissue engineering applications: a review. Tissue Eng. 2006, 12, 1197-1211. 
21. Salles, V.; Seveyrat, L.; Fiorido, T.; Hu, L.; Galineau, J.; Eid, C.; Guiffard, B.; Brioude, 
A.; Guyomar, D., Synthesis and Characterization of Advanced Carbon-Based Nanowires – Study 
of Composites Actuation Capabilities Containing These Nanowires as Fillers. Recent Advances, 
Chapter 13, Prof. Xihong Peng (Ed.), ISBN: 978-953-51-0898-6, InTech, 2012, DOI: 
10.5772/54384. 
22. Hu, X.; Liu, S.; Zhou, G.; Huang, Y.; Xie, Z.; Jing, X., Electrospinning of polymeric 
nanofibers for drug delivery applications. J. Control. Release 2014, 185, 12-21. 
23. Sridhar, R.; Sundarrajan, S.; Venugopal, J. R.; Ravichandran, R.; Ramakrishna, S., 
Electrospun inorganic and polymer composite nanofibers for biomedical applications.                
J. Biomater. Sci., Polym. Ed. 2013, 24, 365-385. 
24. Ji, W.; Sun, Y.; Yang, F.; van den Beucken, J. J.; Fan, M.; Chen, Z.; Jansen, J. A., 
Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering 
applications. Pharm. Res. 2011, 28, 1259-1272. 
25. Zamani, M.; Prabhakaran, M. P.; Ramakrishna, S., Advances in drug delivery via 
electrospun and electrosprayed nanomaterials. Int. J. Nanomedicine 2013, 8, 2997-3017. 
26. He, S.; Xia, T.; Wang, H.; Wei, L.; Luo, X.; Li, X., Multiple release of polyplexes of 
plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature 
blood vessels. Acta Biomater. 2012, 8, 2659-2669. 
58 
 
27. Nie, H.; Ho, M. L.; Wang, C. K.; Wang, C. H.; Fu, Y. C., BMP-2 plasmid loaded 
PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials 2009, 
30, 892-901. 
28. Decher, G.; Hong, J. D.; Schmitt, J., Buildup of ultrathin multilayer films by a self-
assembly process: III. Consecutively alternating adsorption of anionic and cationic 
polyelectrolytes on charged surfaces. Thin Sol. Films 1992, 210–211, Part 2, 831-835. 
29. Castleberry, S. A.; Li, W.; Deng, D.; Mayner, S.; Hammond, P. T., Capillary flow layer-
by-layer: a microfluidic platform for the high-throughput assembly and screening of nanolayered 
film libraries. ACS Nano 2014, 8, 6580-6589. 
30. Finnemore, A.; Cunha, P.; Shean, T.; Vignolini, S.; Guldin, S.; Oyen, M.; Steiner, U., 
Biomimetic layer-by-layer assembly of artificial nacre. Nat. Commun. 2012, 3, 966. 
31. Luo, Y.; Wang, S.; Shen, M.; Qi, R.; Fang, Y.; Guo, R.; Cai, H.; Cao, X.; Tomás, H.; 
Zhu, M.; Shi, X., Carbon nanotube-incorporated multilayered cellulose acetate nanofibers for 
tissue engineering applications. Carbohydr. Polym.  2013, 91, 419-427. 
32. Xi, M.; Jin, J.; Zhang, B.-y., Surface modification of poly(propylene carbonate) by layer-
by-layer assembly and its hemocompatibility. RSC Advances 2014, 4, 38943-38950. 
33. Ruesing, J.; Rotan, O.; Gross-Heitfeld, C.; Mayer, C.; Epple, M., Nanocapsules of a 
cationic polyelectrolyte and nucleic acid for efficient cellular uptake and gene transfer. J. Mater. 
Chem. B 2014, 2, 4625-4630. 
34. Su, Y.; Li, X.; Wang, H.; He, C.; Mo, X., Fabrication and characterization of biodegradable 
nanofibrous mats by mix and coaxial electrospinning. J. Mater. Sci: Mater. Med. 2009, 20, 2285-
2294. 
59 
 
35. Brena, B.; Batista-Viera, F., Immobilization of Enzymes. In Immobilization of Enzymes 
and Cells, Guisan, J., Ed. Humana Press: 2006, 22, 15-30. 
36. Gupta, A.; Terrell, J. L.; Fernandes, R.; Dowling, M. B.; Payne, G. F.; Raghavan, S. R.; 
Bentley, W. E., Encapsulated fusion protein confers "sense and respond" activity to chitosan-
alginate capsules to manipulate bacterial quorum sensing. Biotechnol. Bioeng. 2013, 110, 552-
562. 
37. Arora, S.; Gupta, S.; Narang, R. K.; Budhiraja, R. D., Amoxicillin loaded chitosan-
alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori. 
Sci Pharm. 2011, 79, 673-694. 
38. Carneiro-da-Cunha, M. G.; Cerqueira, M. A.; Souza, B. W. S.; Teixeira, J. A.; Vicente, 
A. A., Influence of concentration, ionic strength and pH on zeta potential and mean 
hydrodynamic diameter of edible polysaccharide solutions envisaged for multinanolayered films 
production. Carbohydr. Polym.  2011, 85, 522-528. 
39.     Enquist-Newman, M.; Faust, A. M. E.; Bravo, D. D.; Santos, C. N. S.; Raisner, R. M.; 
Hanel, A.; Sarvabhowman, P.; Le, C.; Regitsky, D. D.; Cooper, S. R.; Peereboom, L.; Clark, A.; 
Martinez, Y.; Goldsmith, J.; Cho, M. Y.; Donohoue, P. D.; Luo, L.; Lamberson, B.; Tamrakar, 
P.; Kim, E. J.; Villari, J. L.; Gill, A.; Tripathi, S. A.; Karamchedu, P.; Paredes, C. J.; 
Rajgarhia,V.; Kotlar, H. K.; Bailey, R. B.; Miller, D. J.; Ohler, N. L.; Swimmer, C.; Yoshikuni, 
Y., Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform. 
Nature 2014, 505, 239-243. 
40. Silva, T. H.; Alves, A.; Ferreira, B. M.; Oliveira, J. M.; Reys, L. L.; Ferreira, R. J. F.; 
Sousa, R. A.; Silva, S. S.; Mano, J. F.; Reis, R. L., Materials of marine origin: a review on 
polymers and ceramics of biomedical interest. Int. Mater. Rev. 2012, 57, 276-306. 
60 
 
41. Draget, K. I.; Smidsrød, O.; Skjåk-Bræk, G., Alginates from Algae. In Biopolymers Online, 
Wiley-VCH Verlag GmbH & Co. KGaA: 2005. 
42. Draget, K. I.; Skjåk-Bræk, G.; Smidsrød, O., Alginate based new materials. Int. J. Biol. Mac-
romol.  1997, 21, 47-55. 
43. Khoushab, F.; Yamabhai, M., Chitin research revisited. Mar. Drugs 2010, 8, 1988-2012. 
44. de Alvarenga, E. S.; Pereira de Oliveira, C.; Roberto Bellato, C., An approach to 
understanding the deacetylation degree of chitosan. Carbohydr. Polym. 2010, 80, 1155-1160. 
45. Dimzon, I. K.; Ebert, J.; Knepper, T. P., The interaction of chitosan and olive oil: effects 
of degree of deacetylation and degree of polymerization. Carbohydr. Polym. 2013, 92, 564-570. 
46. Huang, S. H.; Wei, L. S.; Chu, H. T.; Jiang, Y. L., Light-addressed electrodeposition of 
enzyme-entrapped chitosan membranes for multiplexed enzyme-based bioassays using a digital 
micromirror device. Sensors  2013, 13, 10711-10724. 
47. Balamurugan, M., Chitosan: A perfect polymer used in fabricating gene delivery and 
novel drug delivery systems.  Int. J. Pharm. Pharm. Sci. 2012, 4, 975-1491. 
48. Croisier, F.; Jérôme, C., Chitosan-based biomaterials for tissue engineering. Eur. Polym. 
J. 2013, 49, 780-792. 
49. Song, Z.; Feng, R.; Sun, M.; Guo, C.; Gao, Y.; Li, L.; Zhai, G., Curcumin-loaded PLGA-
PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in 
vivo. J. Colloid Interface Sci. 2011, 354, 116-123. 
50. Locatelli, E.; Comes Franchini, M., Biodegradable PLGA-b-PEG polymeric 
nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system.        
J. Nanopart. Res. 2012, 14, 1-17. 
61 
 
51. Danhier, F.; Ansorena, E.; Silva, J. M.; Coco, R.; Le Breton, A.; Preat, V., PLGA-based 
nanoparticles: an overview of biomedical applications. J. Controlled Release B 2012, 161, 505-
522. 
52.        Makadia, H. K.; Siegel, S. J., Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable 
Controlled Drug Delivery Carrier. Polymers 2011, 3, 1377-1397. 
53. Yu, J.; Lee, A. R.; Lin, W. H.; Lin, C. W.; Wu, Y. K.; Tsai, W. B., Electrospun PLGA 
fibers incorporated with functionalized biomolecules for cardiac tissue engineering. Tissue Eng. 
Part A 2014, 20, 1896-1907. 
54. Harrington, H. C.; Rose, F. R. A. J.; Reinwald, Y.; Buttery, L. D. K.; Ghaemmaghami, A. 
M.; Aylott, J. W., Electrospun PLGA fibre sheets incorporating fluorescent nanosensors: self-
reporting scaffolds for application in tissue engineering. Anal. Meth. 2013, 5, 68-71. 
55. Sahoo, S.; Toh, S. L.; Goh, J. C. H., A bFGF-releasing silk/PLGA-based biohybrid 
scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. 
Biomaterials 2010, 31, 2990-2998. 
56. Pan, Z.; Ding, J., Poly(lactide-co-glycolide) porous scaffolds for tissue engineering and 
regenerative medicine. Interface Focus 2012, 2, 366-377. 
57. Gang, E. H.; Ki, C. S.; Kim, J. W.; Lee, J.; Cha, B. G.; Lee, K. H.; Park, Y. H., Highly 
porous three-dimensional poly(lactide-co-glycolide) (PLGA) microfibrous scaffold prepared by 
electrospinning method: A comparison study with other PLGA type scaffolds on its biological 
evaluation. Fiber Polym. 2012, 13, 685-691. 
58. Barrett, T.; Ravizzini, G.; Choyke, P. L.; Kobayashi, H., Dendrimers in medical 
nanotechnology. IEEE Eng. Med. Biol. Mag. 2009, 28, 12-22. 
62 
 
59. Barata, T. S.; Brocchini, S.; Teo, I.; Shaunak, S.; Zloh, M., From sequence to 3D 
structure of hyperbranched molecules: application to surface modified PAMAM dendrimers. J. 
Mol. Model. 2011, 17, 2741-2749. 
60. Walter, M. V.; Malkoch, M., Simplifying the synthesis of dendrimers: accelerated 
approaches. Chem. Soc. Rev.  2012, 41, 4593-4609. 
61. Sadekar, S.; Ghandehari, H., Transepithelial transport and toxicity of PAMAM 
dendrimers: implications for oral drug delivery. Adv. Drug Deliv. Rev. 2012, 64, 571-588. 
62. Mastorakos, P.; Kambhampati, S. P.; Mishra, M. K.; Wu, T. T.; Song, E.; Hanes, J.; 
Kannan, R., Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human 
retinal pigment epithelial cells. Nanoscale 2014. DOI: 10.1039/C4NR04284K. 
63. Parrott, M. C.; Benhabbour, S. R.; Saab, C.; Lemon, J. A.; Parker, S.; Valliant, J. F.; 
Adronov, A., Synthesis, Radiolabeling, and Bio-imaging of High-Generation Polyester 
Dendrimers. J. Amer. Chem. Soc. 2009, 131, 2906-2916. 
64. Labieniec, M.; Watala, C., PAMAM dendrimers — diverse biomedical applications. 
Facts and unresolved questions. Cent. Eur. J. Biol. 2009, 4, 434-451. 
65. Nandy, B.; Maiti, P. K., DNA Compaction by a Dendrimer. J. Phys. Chem. B 2010, 115, 
217-230. 
66. Froehlich, E.; Mandeville, J. S.; Weinert, C. M.; Kreplak, L.; Tajmir-Riahi, H. A., 
Bundling and aggregation of DNA by cationic dendrimers. Biomacromolecules 2011, 12, 511-
517. 
67. Langereis, S.; Dirksen, A.; Hackeng, T. M.; van Genderen, M. H. P.; Meijer, E. W.,  
Dendrimers and magnetic resonance imaging. New J. Chem.  2007, 31, 1152-1160. 
63 
 
68. Jevprasesphant, R.; Penny, J.; Attwood, D.; McKeown, N. B.; D'Emanuele, A., 
Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. 
Pharm. Res. 2003, 20, 1543-1550. 
69. Madaan, K.; Kumar, S.; Poonia, N.; Lather, V.; Pandita, D., Dendrimers in drug delivery 
and targeting: Drug-dendrimer interactions and toxicity issues. J. Pharm. Bioall. Sci. 2014, 6, 
139-150. 
70. Wang, S.; Cheng, H.; Dai, G.; Wang, X.; Hua, R.; Liu, X.; Wang, P.; Chen, G.; Yue, W.; 
An, Y., Umbilical cord mesenchymal stem cell transplantation significantly improves 
neurological function in patients with sequelae of traumatic brain injury. Brain res. 2013, 1532, 
76-84. 
71. Lau, A. N.; Goodwin, M.; Kim, C. F.; Weiss, D. J., Stem cells and regenerative medicine 
in lung biology and diseases. Mol .Ther. 2012, 20, 1116-1130. 
72. Ko, I. K.; Lee, S. J.; Atala, A.; Yoo, J. J., In situ tissue regeneration through host stem 
cell recruitment. Exp. Mol. Med. 2013, 45, e57. 
73. Lane, S. W.; Williams, D. A.; Watt, F. M., Modulating the stem cell niche for tissue 
regeneration. Nat. Biotechnol. 2014, 32, 795-803. 
74. Pigott, J. H.; Ishihara, A.; Wellman, M. L.; Russell, D. S.; Bertone, A. L., Investigation of 
the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after 
intra-articular injection in horses. Vet. Immunol. Immunopathol. 2013, 156, 99-106. 
75. Cohen, J. A., Mesenchymal stem cell transplantation in multiple sclerosis. J. Neurol. Sci. 
2013, 333, 43-49. 
64 
 
76. Buja, L. M.; Vela, D., Immunologic and inflammatory reactions to exogenous stem cells 
implications for experimental studies and clinical trials for myocardial repair. J. Am. Coll. 
Cardiol. 2010, 56, 1693-1700. 
77. Amini, A. R.; Laurencin, C. T.; Nukavarapu, S. P., Bone Tissue Engineering: Recent 
Advances and Challenges. Crit. Rev. Biomed. 2012, 40, 363-408. 
78. Liao, J.; Hu, N.; Zhou, N.; Lin, L.; Zhao, C.; Yi, S.; Fan, T.; Bao, W.; Liang, X.; Chen, 
H.; Xu, W.; Chen, C.; Cheng, Q.; Zeng, Y.; Si, W.; Yang, Z.; Huang, W., Sox9 Potentiates 
BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic 
Differentiation. PLOS ONE 2014, 9, e89025. 
79. Murphy, M. B.; Moncivais, K.; Caplan, A. I., Mesenchymal stem cells: environmentally 
responsive therapeutics for regenerative medicine. Exp. Mol. Med. 2013, 45, e54. 
80. Wang, S.; Zheng, F.; Huang, Y.; Fang, Y.; Shen, M.; Zhu, M.; Shi, X., Encapsulation of 
Amoxicillin within Laponite-Doped Poly(lactic-co-glycolic acid) Nanofibers: Preparation, 
Characterization, and Antibacterial Activity. ACS Appl. Mater. Interfaces 2012, 4, 6393-6401. 
81. Zheng, F.; Wang, S.; Wen, S.; Shen, M.; Zhu, M.; Shi, X., Characterization and 
antibacterial activity of amoxicillin-loaded electrospun nano-hydroxyapatite/poly(lactic-co-
glycolic acid) composite nanofibers. Biomaterials 2013, 34, 1402-1412. 
82. Singh, L.; Kumar, V.; Ratner, B. D., Generation of porous microcellular 85/15 poly (DL-
lactide-co-glycolide) foams for biomedical applications. Biomaterials 2004, 25, 2611-2617. 
83. Wu, G.; Dong, C.; Wang, G.; Gao, W.; Fan, H.; Xiao, W.; Zhang, L., Preparation of 
three-dimensional porous scaffold of PLGA-silk fibroin-collagen nanofiber and its 
cytocompatibility study. Chin. J. Rep. Reconstruct. Surg. 2009, 23, 1007-1011. 
65 
 
84. Yamanlar, S.; Sant, S.; Boudou, T.; Picart, C.; Khademhosseini, A., Surface 
functionalization of hyaluronic acid hydrogels by polyelectrolyte multilayer films. Biomaterials 
2011, 32, 5590-5599. 
85. Zhu, X.; Zhang, Z.; Wang, K.; Yang, J.; Xu, X.; Men, X.; Zhou, X., A facile route to 
mechanically durable responsive surfaces with reversible wettability switching. New J. Chem.  
2012, 36, 1280-1284. 
86. Ma, O.; Lavertu, M.; Sun, J.; Nguyen, S.; Buschmann, M. D.; Winnik, F. M.; Hoemann, 
C. D., Precise derivatization of structurally distinct chitosans with rhodamine B isothiocyanate. 
Carbohydr. Polym.  2008, 72, 616-624. 
87. Liu, J.; Zhang, Y.; Yang, T.; Ge, Y.; Zhang, S.; Chen, Z.; Gu, N., Synthesis, 
characterization, and application of composite alginate microspheres with magnetic and 
fluorescent functionalities. J. Appl. Polym. Sci. 2009, 113, 4042-4051. 
88. Wang, S.; Zheng, F.; Huang, Y.; Fang, Y.; Shen, M.; Zhu, M.; Shi, X., Encapsulation of 
amoxicillin within laponite-doped poly(lactic-co-glycolic acid) nanofibers: preparation, 
characterization, and antibacterial activity. ACS Appl. Mater. Interfaces 2012, 4, 6393-6401. 
89.     Deng, H.; Zhou, X.; Wang, X.; Zhang, C.; Ding, B.; Zhang, Q.; Du, Y., Layer-by-layer 
structured polysaccharides film-coated cellulose nanofibrous mats for cell culture. Carbohydr. 
Polym.  2010, 80, 474-479. 
90.       Shukla, A.; Almeida, B., Advances in cellular and tissue engineering using layer-by-layer 
assembly. Nanomed. Nanobiotechnol. 2014, 6, 411-421. 
91.       Khayet, M., Polymeric Nano-Fibers and Modified Nano-Fibers Assembly in 3D Network 
for Different Potential Applications. J. Mater. Sci. NanoTechnol.  2013, 1, 1-4. 
66 
 
92.    Tan, G.-K.; Dinnes, D. L. M.; Cooper-White, J. J., Modulation of collagen II fiber 
formation in 3-D porous scaffold environments. Acta Biomater. 2011, 7, 2804-2816. 
93.     Lawrie, G.; Keen, I.; Drew, B.; Chandler-Temple, A.; Rintoul, L.; Fredericks, P.; 
Grøndahl, L., Interactions between Alginate and Chitosan Biopolymers Characterized Using 
FTIR and XPS. Biomacromolecules 2007, 8, 2533-2541. 
94.  Navarro, G.; Maiwald, G.; Haase, R.; Rogach, A. L.; Wagner, E.; de Ilarduya, C. T.; 
Ogris, M., Low generation PAMAM dendrimer and CpG free plasmids allow targeted and 
extended transgene expression in tumors after systemic delivery.  J. Control. Release 2010, 146, 
99-105. 
95. Nandy, B.; Santosh, M.; Maiti, P., Interaction of nucleic acids with carbon nanotubes and 
dendrimers. J. Biosci. 2012, 37, 457-474. 
96. Nam, H. Y.; Hahn, H. J.; Nam, K.; Choi, W. H.; Jeong, Y.; Kim, D. E.; Park, J. S., 
Evaluation of generations 2, 3 and 4 arginine modified PAMAM dendrimers for gene delivery. 
Int. J. Pharm. 2008, 363, 199-205. 
97. Luu, Y. K.; Kim, K.; Hsiao, B. S.; Chu, B.; Hadjiargyrou, M., Development of a 
nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block 
copolymers. J. Control. Release.  2003, 89, 341-353. 
98. Qi, R.; Guo, R.; Shen, M.; Cao, X.; Zhang, L.; Xu, J.; Yu, J.; Shi, X., Electrospun 
poly(lactic-co-glycolic acid)/halloysite nanotube composite nanofibers for drug encapsulation 
and sustained release. J. Mater. Chem. 2010, 20, 10622-10629. 
99. Santos, J. L.; Nouri, A.; Fernandes, C.; Rodrigues, J.; Tomás, H., Gene delivery using 
biodegradable polyelectrolyte microcapsules prepared through the layer-by-layer technique. 
Biotechnol. Progr. 2012, 28, 1088-1094. 
67 
 
100. Goncalves, M.; Castro, R.; Rodrigues, J.; Tomás, H., The effect of PAMAM dendrimers 
on mesenchymal stem cell viability and differentiation. Curr. Med. Chem. 2012, 19, 4969-4975. 
101. Khanlou, H. M.; Sadollah, A.; Ang, B. C.; Kim, J. H.; Talebian, S.; Ghadimi, A., 
Prediction and optimization of electrospinning parameters for polymethyl methacrylate nanofiber 
fabrication using response surface methodology and artificial neural networks. Neural. Comput. 
Appl. 2014, 25, 767-777. 
102. Seo, H. J.; Yu, S. M.; Lee, S. H.; Choi, J. B.; Park, J. C.; Kim, J. K., Effect of PLGA 
Nano-Fiber/Film Composite on HUVECs for Vascular Graft Scaffold. In 13th International 
Conference on Biomedical Engineering, Lim, C.; Goh, J. H., Eds. 2009; 23, 2147-2150. 
103. Peng, S. F.; Su, C. J.; Wei, M. C.; Chen, C. Y.; Liao, Z. X.; Lee, P. W.; Chen, H. L.; 
Sung, H. W., Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and 
gene expression. Biomaterials 2010, 31, 5660-5670. 
104. Wang, H.; Shi, H. B.; Yin, S. K., Polyamidoamine dendrimers as gene delivery carriers in 
the inner ear: How to improve transfection efficiency. Exp. Ther. Med. 2011, 2, 777-781. 
105. Kim, T. I.; Bai, C. Z.; Nam, K.; Park, J. S., Comparison between arginine conjugated 
PAMAM dendrimers with structural diversity for gene delivery systems. J. Control. Release  
2009, 136, 132-139. 
106. Santos, J. L.; Oliveira, H.; Pandita, D.; Rodrigues, J.; Pêgo, A. P.; Granja, P. L.; Tomás, 
hH., Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved 
gene delivery in mesenchymal stem cells. J. Control. Release  2010, 144, 55-64. 
107. Jang, J. H.; Bengali, Z.; Houchin, T. L.; Shea, L. D., Surface adsorption of DNA to tissue 
engineering scaffolds for efficient gene delivery. J. Biomed. Mater. Res. Part A 2006, 77, 50-58. 
68 
 
108. Qi, R.; Shen, M.; Cao, X.; Guo, R.; Tian, X.; Yu, J.; Shi, X., Exploring the dark side of 
MTT viability assay of cells cultured onto electrospun PLGA-based composite nanofibrous 
scaffolding materials. The Analyst 2011, 136, 2897-2903. 
109. He, C. X.; Tabata, Y.; Gao, J. Q., Non-viral gene delivery carrier and its three-
dimensional transfection system. Int. J. Pharm. 2010, 386, 232-242. 
110. Alves, H.; Dechering, K.; Van Blitterswijk, C.; De Boer, J., High-Throughput Assay for 
the Identification of Compounds Regulating Osteogenic Differentiation of Human Mesenchymal 
Stromal Cells. PLOS ONE 2011, 6, e26678. 
111. Mason, S. S.; Kohles, S. S.; Winn, S. R.; Zelick, R. D., Extrahepatic 25-Hydroxylation of 
Vitamin D3 in an Engineered Osteoblast Precursor Cell Line Exploring the Influence on Cellular 
Proliferation and Matrix Maturation during Bone Development. Bio-Med. Eng. 2013, 2013, 1-11. 
 
 
 
 
 
 
 
 
 
69 
 
           
 
 
 
 
 
 
 
 
 
     
       GOVERNO DA REPÚBLICA PORTUGUESA                              UNIÃO EUROPEIA                                     REGIÃO AUTÓNOMA DA MADEIRA 
